Clinical Trials Browser

OTHER × Osteosarcoma × Fluoridation × Clear all

NCT05024253 2024-02-07

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Phase 3 Completed

Osteosarcoma